Fennec Pharmaceuticals
D

FENC

10.110
USD
-0.02
(-0.20%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-84
حجم السوق
354,528,977
أصول ذات صلة

العنوان: Fennec Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.